口头报告题目:Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation
京公网安备11010502032929号
工商备案公示信息
京ICP证050801号
京ICP备12003651号